Skip to main content
. Author manuscript; available in PMC: 2019 May 15.
Published in final edited form as: Bioorg Med Chem. 2018 Feb 2;26(9):2251–2261. doi: 10.1016/j.bmc.2018.01.024

Scheme 2.

Scheme 2

Reagents and conditions: (a) LDA, THF, −78 °C, 30 min; (b) R1CHO, r.t., 16 h; (c) Et3SiH, TFA, DCM, r.t., 16 h; (d) 57% aq. HI, acetic acid, 100 °C, 4 h; *compound was purchased.